Biotechnology Company Partnership Files Major International Patent Applications
SciSparc and Clearmind: A Revolutionary Partnership Paving the Way for Psychedelic Medicine.
In a groundbreaking move in the field of psychedelic medicine, SciSparc (NASDAQ: $SPRC) and Clearmind have jointly filed three new international patent applications. The patents are for novel compounds of MDMA, Ibogaine, and Ketamine, signaling a significant stride in the research and development of these substances for therapeutic use.
